Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Operating Margin (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed Operating Margin for 10 consecutive years, with 494.9% as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Operating Margin changed N/A year-over-year to 494.9%, compared with a TTM value of 2007.9% through Sep 2025, changed N/A, and an annual FY2024 reading of 2240.9%, changed N/A over the prior year.
  • Operating Margin was 494.9% for Q4 2024 at Lisata Therapeutics, down from 256253.3% in the prior quarter.
  • Across five years, Operating Margin topped out at 494.9% in Q4 2024 and bottomed at 494.9% in Q4 2024.